Finance

Lists
Why is CTMX up 4.05%?
Dive Deeper
CTMX:NASDAQ
CytomX Therapeutics Inc
$2.57
+4.05%
(+0.100) 1D
$2.57
0.00% (0.00)
After hours
Closed: Oct 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTMX...
Open
$2.46
High
$2.58
Low
$2.44
Mkt. cap
560.00M
Avg. vol.
3.92M
Volume
3.04M
52-wk high
$8.20
52-wk low
$2.43
EPS
-$0.46
Beta
2.21
Shares outstanding
217.90M
No. of employees
69
Open
$2.46
High
$2.58
Low
$2.44
Mkt. cap
560.00M
Avg. vol.
3.92M
Volume
3.04M
52-wk high
$8.20
52-wk low
$2.43
EPS
-$0.46
Beta
2.21
Shares outstanding
217.90M
No. of employees
69
News stories
From web sources and news partners
About CytomX Therapeutics Inc
CEO-
Employees69
Founded2008
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytomx.com
Analyst ratings
Based on 4 analysts giving stock ratings to CTMX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CTMX in the last 3 months.
Highest
Current $2.57
$16.00 (+522.57%)
Average
$13.25 (+415.56%)
Lowest
$11.00 (+328.02%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$12.00
+366.9%
09/23/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$11.00
+328%
08/17/2026
Etzer Darout
Barclays
Buy
Maintained
$16.00
+522.6%
08/07/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$14.00
+444.7%
08/07/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$11.00
+328%
06/04/2026
Kalpit Patel
Wolfe Research
Buy
Initiated
$6.00
+133.5%
05/19/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
$12.00
+366.9%
05/13/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Maintained
$11.00
+328%
05/11/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
$12.00
+366.9%
03/20/2026
Roger Song
Jefferies
Buy
Reiterated
$16.00
+522.6%
03/18/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
-$0.09 / -$0.10
+10.98%beat
Revenue / Est. (USD)
1.42M / 12.34M
-88.51%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-238.62%
-3,998.49%
-177.89%
-1,457.40%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps